EUVIMEDEUVIMED entdecken
Open Access

YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy

Ziqian Zhang, Zhangyi Luo iD, Haozhe Huang, Yixian Huang, Jieni Xu, Xian-You Liu, Wei Zhang iD, Song Li, Jingjing Sun iD

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.4c01076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Ziqian Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacogenetics, Department of Pharmaceutical Science, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15261, Unite…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Adaptor Proteins, Signal Transducing, Breast Neoplasms, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, David and Betty Brenneman Scholar Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsAdaptor Proteins, Signal TransducingBreast NeoplasmsTranscription FactorsProtein Kinase InhibitorsAntineoplastic AgentsHumansAnimalsMiceFemaleCell Line, TumorYAP-Signaling ProteinsNanoparticlesProdrugsDasatinibMice, NudeXenograft Model Antitumor AssaysTranscriptional Coactivator with PDZ-Binding Motif Proteins

Substanzen

Adaptor Proteins, Signal TransducingYAP-Signaling ProteinsTranscription FactorsYAP1 protein, humanProtein Kinase InhibitorsProdrugsDasatinibAntineoplastic AgentsTranscriptional Coactivator with PDZ-Binding Motif Proteins

Autor:innen und Institutionen

  • Center for Pharmacogenetics, Department of Pharmaceutical Science, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15261, United States.
  • Department of Pharmaceutical Science, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15261, United States.
  • Department of Chemistry, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania 15213, United States.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68105, United States.

ORCID-Profile: Zhangyi Luo, Wei Zhang, Jingjing Sun

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • David and Betty Brenneman Scholar Fund

Zitieren

APA

Zhang, Z., Luo, Z., Huang, H., Huang, Y., Xu, J., Liu, X. Y., Zhang, W., Li, S., & Sun, J. (2025). YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c01076

Vancouver

Zhang Z, Luo Z, Huang H, Huang Y, Xu J, Liu XY, et al. YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy. Biomacromolecules. 2025. doi:10.1021/acs.biomac.4c01076

BibTeX
@article{Zhang2025,
  author = {Zhang, Ziqian and Luo, Zhangyi and Huang, Haozhe and Huang, Yixian and Xu, Jieni and Liu, Xian-You and Zhang, Wei and Li, Song and Sun, Jingjing},
  title = {YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.4c01076}
}
Kostenlos starten →